Association between muscle strength and advanced fibrosis in non-alcoholic fatty liver disease: a Korean nationwide survey

被引:48
作者
Kang, Sunyoung [1 ,2 ]
Moon, Min Kyong [1 ,3 ]
Kim, Won [1 ,4 ]
Koo, Bo Kyung [1 ,3 ]
机构
[1] Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea
[2] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
[3] Seoul Natl Univ, Seoul Metropolitan Govt, Boramae Med Ctr, Dept Internal Med,Div Endocrinol, 20 Boramae Ro 5 Gil, Seoul 07061, South Korea
[4] Seoul Natl Univ, Seoul Metropolitan Govt, Boramae Med Ctr, Div Gastroenterol & Hepatol,Dept Internal Med, 20 Boramae Ro 5 Gil, Seoul 07061, South Korea
基金
新加坡国家研究基金会;
关键词
Hepatic steatosis; Hepatic fibrosis; Muscle strength; Sarcopenia; Insulin resistance; ALL-CAUSE MORTALITY; INSULIN-RESISTANCE; AMERICAN ASSOCIATION; PRACTICE GUIDELINE; BODY-COMPOSITION; SARCOPENIA; DIAGNOSIS; EXERCISE; NAFLD; RISK;
D O I
10.1002/jcsm.12598
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background We investigated the association between muscle strength and the prevalence of advanced fibrosis among individuals with non-alcoholic fatty liver disease (NAFLD) using a nationwide cross-sectional survey. Methods Individuals, 20 to 79 years of age, from the Korean National Health and Nutrition Examination Surveys (KNHANES) from 2014 to 2016 were selected (N = 14 861), with sample weights applied. Muscle strength was quantified as the handgrip strength divided by the body mass index (BMI); low muscle strength (LMS) was defined as the lowest quartile (Q(1)) of the handgrip strength/BMI for our sample population. NAFLD was defined as hepatic steatosis index >36. Advanced fibrosis was defined as a fibrosis-4 index score >= 1.30 (Fibrosis(FIB4)). Results The mean age of the study population was 45.6 +/- 0.2 years, and 42.4% were male. As muscle strength increased, the mean BMI and age decreased accordingly, and the proportions of diabetes, dyslipidaemia, hypertension, and obesity decreased significantly (P < 0.001 for all). In a crude analysis, the LMS was associated with an increased prevalence of NAFLD (odds ratio [OR] 3.62, 95% confidence interval [CI] 3.25-4.03,P < 0.001), which remained significant even after adjustment for age, sex, obesity, insulin resistance, diabetes, hypertension, dyslipidaemia, and high-sensitivity C-reactive protein (OR 1.66, 95% CI 1.28-2.16,P < 0.001). In this logistic regression model, the prevalence of NAFLD decreased by 24% with each quartile increment in muscle strength (OR 0.76, 95% CI 0.68-0.85,P < 0.001). Among individuals with NAFLD (n = 2092), LMS was significantly associated with the presence of advanced fibrosis (Fibrosis(FIB4)) independently of age, sex, obesity, diabetes, hypertension, dyslipidaemia, and high-sensitivity C-reactive protein (OR 1.66, 95% CI 1.01-2.49,P = 0.015), which lost its statistical significance after additional adjustment for insulin resistance. Conclusions Low muscle strength is independently associated with NAFLD. The significant association between LMS and advanced fibrosis in NAFLD may be mediated through insulin resistance.
引用
收藏
页码:1232 / 1241
页数:10
相关论文
共 51 条
[1]  
American Diabetes Association, 2019, CARE, V42, pS103, DOI [10.2337/dc195010, DOI 10.2337/DC19-S002, DOI 10.2337/dc19-S002]
[2]   Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study [J].
Armstrong, Matthew James ;
Gaunt, Piers ;
Aithal, Guruprasad P. ;
Barton, Darren ;
Hull, Diana ;
Parker, Richard ;
Hazlehurst, Jonathan M. ;
Guo, Kathy ;
Abouda, George ;
Aldersley, Mark A. ;
Stocken, Deborah ;
Gough, Stephen C. ;
Tomlinson, Jeremy W. ;
Brown, Rachel M. ;
Huebscher, Stefan G. ;
Newsome, Philip N. .
LANCET, 2016, 387 (10019) :679-690
[3]   Health Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis [J].
Beaudart, Charlotte ;
Zaaria, Myriam ;
Pasleau, Francoise ;
Reginster, Jean-Yves ;
Bruyere, Olivier .
PLOS ONE, 2017, 12 (01)
[4]   A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis [J].
Belfort, Renata ;
Harrison, Stephen A. ;
Brown, Kenneth ;
Darland, Celia ;
Finch, Joan ;
Hardies, Jean ;
Balas, Bogdan ;
Gastaldelli, Amalia ;
Tio, Fermin ;
Pulcini, Joseph ;
Berria, Rachele ;
Ma, Jennie Z. ;
Dwivedi, Sunil ;
Havranek, Russell ;
Fincke, Chris ;
DeFronzo, Ralph ;
Bannayan, George A. ;
Schenker, Steven ;
Cusi, Kenneth .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (22) :2297-2307
[5]   The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association [J].
Chalasani, Naga ;
Younossi, Zobair ;
Lavine, Joel E. ;
Diehl, Anna Mae ;
Brunt, Elizabeth M. ;
Cusi, Kenneth ;
Charlton, Michael ;
Sanyal, Arun J. .
HEPATOLOGY, 2012, 55 (06) :2005-2023
[6]   The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology [J].
Chalasani, Naga ;
Younossi, Zobair ;
Lavine, Joel E. ;
Diehl, Anna Mae ;
Brunt, Elizabeth M. ;
Cusi, Kenneth ;
Charlton, Michael ;
Sanyal, Arun J. .
GASTROENTEROLOGY, 2012, 142 (07) :1592-1609
[7]   Sarcopenia: revised European consensus on definition and diagnosis [J].
Cruz-Jentoft, Alfonso J. ;
Bahat, Gulistan ;
Bauer, Juergen ;
Boirie, Yves ;
Bruyere, Olivier ;
Cederholm, Tommy ;
Cooper, Cyrus ;
Landi, Francesco ;
Rolland, Yves ;
Sayer, Avan Aihie ;
Schneider, Stephane M. ;
Sieber, Cornel C. ;
Topinkova, Eva ;
Vandewoude, Maurits ;
Visser, Marjolein ;
Zamboni, Mauro .
AGE AND AGEING, 2019, 48 (01) :16-31
[8]   Sarcopenia: European consensus on definition and diagnosis [J].
Cruz-Jentoft, Alfonso J. ;
Baeyens, Jean Pierre ;
Bauer, Juergen M. ;
Boirie, Yves ;
Cederholm, Tommy ;
Landi, Francesco ;
Martin, Finbarr C. ;
Michel, Jean-Pierre ;
Rolland, Yves ;
Schneider, Stephane M. ;
Topinkova, Eva ;
Vandewoude, Maurits ;
Zamboni, Mauro .
AGE AND AGEING, 2010, 39 (04) :412-423
[9]   Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels [J].
Ferrucci, L ;
Penninx, BWJH ;
Volpato, S ;
Harris, TB ;
Bandeen-Roche, K ;
Balfour, J ;
Leveille, SG ;
Fried, LP ;
Guralnik, JM .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2002, 50 (12) :1947-1954
[10]   Supraphysiological hyperinsulinaemia is necessary to stimulate skeletal muscle protein anabolism in older adults: evidence of a true age-related insulin resistance of muscle protein metabolism [J].
Fujita, S. ;
Glynn, E. L. ;
Timmerman, K. L. ;
Rasmussen, B. B. ;
Volpi, E. .
DIABETOLOGIA, 2009, 52 (09) :1889-1898